In a report released yesterday, Lorenzo Biasio from Credit Suisse maintained a Hold rating on Pfizer (PFE - Research Report), with a price target of $42.00. The company's shares closed yesterday at $47.09.According to TipRanks, Biasio is a 4-star analyst with an average return of 6.8% and a 59.17% success rate. Biasio covers the Healthcare sector, focusing on stocks such as Boston Scientific, Coherus Biosciences, and Edwards Lifesciences.Currently, the analyst consensus on Pfizer is a Moderate Buy with an average price target of $51.00, representing an 8.30% upside. In a report released on November 2, Barclays also maintained a Hold rating on the stock with a $49.00 price target.
https://www.tipranks.com/news/blurbs/credit-suisse-keeps-their-hold-rating-on-pfizer-pfe?utm_source=advfn.com&utm_medium=referral